» Articles » PMID: 31473867

Low-level Laser Therapy for Weight Reduction: a Randomized Pilot Study

Overview
Journal Lasers Med Sci
Publisher Springer
Date 2019 Sep 2
PMID 31473867
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity and overweight is a global health crisis and novel methods of treatment are needed to address it. Low-level laser therapy (LLLT) is a currently available non-invasive procedure for lysing excess fat, but there is a lack of consensus exists on LLLT frequency and limited research from studies of LLLT. The purpose of this pilot study is to compare the effect of three of the most common LLLT frequencies on weight, waist circumference, body fat percentage, and quality of life. Sixty overweight (body mass index (BMI) 25-29.9 kg/m) adult participants were randomized to 12 LLLT treatments: (1) three times weekly for 4 weeks, (2) twice weekly for 6 weeks, or (3) once weekly for 12 weeks. All participants attended an in-person visit at baseline and at weeks 4, 6, 12, and 26. Participants were recruited September 30, 2016 through to August 27, 2017. The majority of the 60 participants were female (90%) with an average age of 43.7 years (± 9.2 years). Most participants (98%) completed 10 or more of the 12 LLLT treatments. When comparing across treatment groups, the greatest reductions from baseline were observed in those assigned to twice weekly for 6 weeks in weight (1 ± 1.7 (±SD) kg by week 6), waist circumference (- 2.0 ± 3.2 in. by week 6 and - 1.5 ± 3.2 in. by week 26), body mass index (- 0.4 ± 0.6 kg/m), and body fat mass (- 1.1 ± 1.6 kg). This group also had the most significant improvement from baseline in quality of life (+ 0.5 ± 0.8 by week 6), body satisfaction (+ 0.2 ± 0.4 by week 6 and week 26), and body appreciation (+ 0.2 ± 0.3 by week 6 and + 0.3 ± 0.3 by week 26). LLLT twice weekly for 6 weeks could be proposed as the optimal frequency and duration for the management of body weight. Trial registration: https://clinicaltrials.gov/ct2/show/NCT02877004. Registered August 24, 2016.

Citing Articles

Photobiomodulation Therapy for Improvement of Body Contour: A Retrospective Study on Middle Eastern Participants.

Eskandari S, Samadi A, Kardeh S, Dowlati Y, Yazdi H, Firooz A Iran J Public Health. 2024; 53(8):1858-1863.

PMID: 39415875 PMC: 11475179. DOI: 10.18502/ijph.v53i8.16291.


Nd:YAG-photobiomodulation enhanced ADSCs multilineage differentiation and immunomodulation potentials.

He L, Zheng Y, Liu M, Dong X, Shen L, He Y Lasers Med Sci. 2023; 38(1):190.

PMID: 37608016 PMC: 10444653. DOI: 10.1007/s10103-023-03818-x.


A Holistic Perspective on How Photobiomodulation May Influence Fatigue, Pain, and Depression in Inflammatory Bowel Disease: Beyond Molecular Mechanisms.

Laakso E, Ewais T Biomedicines. 2023; 11(5).

PMID: 37239169 PMC: 10216148. DOI: 10.3390/biomedicines11051497.


The Effect of Laser Therapy Along With Mediterranean Diet Versus Mediterranean Diet Only on Older Adults With Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial.

Nagy E, Ibrahim F, Jouda A, Elsayed M J Lasers Med Sci. 2021; 12:e39.

PMID: 34733762 PMC: 8558722. DOI: 10.34172/jlms.2021.39.


Evaluation of lipolysis and toxicological parameters of low-level laser therapy at different wavelengths and doses in the abdominal subcutaneous tissue.

Martins M, Martins M, de Souza A, Antunes F, Pail P, Wiilland E Lasers Med Sci. 2021; 37(2):1235-1244.

PMID: 34297266 DOI: 10.1007/s10103-021-03378-y.


References
1.
Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

2.
Rubinstein L, Korn E, Freidlin B, Hunsberger S, Ivy S, Smith M . Design issues of randomized phase II trials and a proposal for phase II screening trials. J Clin Oncol. 2005; 23(28):7199-206. DOI: 10.1200/JCO.2005.01.149. View

3.
Halpern S . Evaluating preference effects in partially unblinded, randomized clinical trials. J Clin Epidemiol. 2003; 56(2):109-15. DOI: 10.1016/s0895-4356(02)00598-x. View

4.
Blissmer B, Riebe D, Dye G, Ruggiero L, Greene G, Caldwell M . Health-related quality of life following a clinical weight loss intervention among overweight and obese adults: intervention and 24 month follow-up effects. Health Qual Life Outcomes. 2006; 4:43. PMC: 1553435. DOI: 10.1186/1477-7525-4-43. View

5.
ONeil P, Smith S, Weissman N, Fidler M, Sanchez M, Zhang J . Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity (Silver Spring). 2012; 20(7):1426-36. DOI: 10.1038/oby.2012.66. View